A safety comparison of heparin and argatroban anticoagulation in veno‐venous extracorporeal membrane oxygenation with a focus on bleeding
Argatroban is an interesting alternative to heparin with less bleeding, less need for red blood cell transfusions and improved safety of ECMO with less mortality-related bleeding.
Authors
- Ondřej Jor (ORCID: https://orcid.org/0000-0002-8002-148X)
- Tereza Romanová (ORCID: https://orcid.org/0000-0001-6222-8922)
- Jaroslav Janos̆ek (ORCID: https://orcid.org/0000-0003-0682-4521)
- Jan Máca (ORCID: https://orcid.org/0000-0002-9771-0468)
- Peter Sklienka (ORCID: https://orcid.org/0000-0002-0330-5323)
- Zuzana Kučerová (ORCID: https://orcid.org/0000-0002-2849-3084)
- Michal Frelich (ORCID: https://orcid.org/0000-0001-7472-9492)
- Filip Burša (ORCID: https://orcid.org/0000-0001-9770-1433)
- Simona Němcová
- Jiří Sagan (ORCID: https://orcid.org/0009-0000-8241-3308)
- Adéla Kondé
Institutions
- VSB - Technical University of Ostrava (CZ)
- University of Ostrava (CZ)
- University Hospital Ostrava (CZ)
- Czech Academy of Sciences, Institute of Physiology (CZ)
Publication Details
- Journal
- Transfusion Medicine
- Published
- 2024-10-07
- DOI
- https://doi.org/10.1111/tme.13102
- Citations
- 5
- Primary Topic
- Mechanical Circulatory Support Devices
- Type
- article
- Field-Weighted Citation Impact
- 0.92
Funders
- Ministerstvo Zdravotnictví Ceské Republiky